QuVa Pharma, Inc.

Form 483 issued June 2, 2017 · Sugar Land, Texas

Inspection
May 23 – Jun 2, 2017
Observations
1
Pages
2
FEI number
3012053582

In short: On June 2, 2017, FDA issued a Form 483 with 1 observation to QuVa Pharma, Inc. in Sugar Land, Texas (FEI 3012053582) after an inspection that ran May 23 – Jun 2, 2017. The investigators were Jason R. Caballero and Shatina R. Alridge. Most observations concern production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.113(b) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at QuVa Pharma, Inc.?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected QuVa Pharma, Inc.?

Jason R. Caballero and Shatina R. Alridge are named on this Form 483, for the inspection of May 23 – Jun 2, 2017. Each investigator has a profile showing what they cite most.

When was QuVa Pharma, Inc. inspected by FDA?

The inspection ran May 23 – Jun 2, 2017, and the Form 483 is dated June 2, 2017.

How do I get the full Form 483 for QuVa Pharma, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free